TY - JOUR
T1 - Vestibular and hearing loss in genetic and metabolic disorders
AU - Gasparini, Paolo
AU - Estivill, Xavier
AU - Fortina, Paolo
PY - 1999
Y1 - 1999
N2 - Hearing loss affects about 4% of people under 45 years of age and comprises a broad spectrum of clinical presentations (congenital or late-onset, conductive or sensorineural, and syndromic or nonsyndromic). Approximately 30% of genetically determined deafness is reported to occur in syndromic form and 70% in nonsyndromic form. This review highlights recent advances in the molecular and genetic basis of hearing loss, which will help in understanding the biology of normal and abnormal hearing.
AB - Hearing loss affects about 4% of people under 45 years of age and comprises a broad spectrum of clinical presentations (congenital or late-onset, conductive or sensorineural, and syndromic or nonsyndromic). Approximately 30% of genetically determined deafness is reported to occur in syndromic form and 70% in nonsyndromic form. This review highlights recent advances in the molecular and genetic basis of hearing loss, which will help in understanding the biology of normal and abnormal hearing.
UR - http://www.scopus.com/inward/record.url?scp=0033015992&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033015992&partnerID=8YFLogxK
U2 - 10.1097/00019052-199902000-00006
DO - 10.1097/00019052-199902000-00006
M3 - Article
C2 - 10097882
AN - SCOPUS:0033015992
VL - 12
SP - 35
EP - 39
JO - Current Opinion in Neurology
JF - Current Opinion in Neurology
SN - 1350-7540
IS - 1
ER -